Oct 6, 2023 8:30 am EDT FOXO Technologies™ Interim CEO Mark White Provides Letter to Shareholders Outlining New AI-Enabled Direct-to-Consumer Strategy and Immediate Expense Reductions
Aug 31, 2023 8:30 am EDT FOXO Technologies Inc. Announces NYSE American Acceptance of Compliance Plan
Aug 18, 2023 4:15 pm EDT FOXO Technologies Inc. Announces Receipt of Second Notice of Non-Compliance from NYSE American
Aug 17, 2023 8:30 am EDT FOXO Technologies™ Collaborates with DataRobot to Pave the Way for AI-Driven Epigenetic Biomarker Research in Human Longevity
Aug 8, 2023 8:30 am EDT FOXO Technologies™ Sets Second Quarter 2023 Business Update Call for Thursday, August 10, 2023 at 3:15 p.m. CT
Aug 7, 2023 8:30 am EDT Longevity Biotech Companies GERO and FOXO Technologies™ to Embark on Joint Initiative on Artificial Intelligence and Epigenetic Data to Discover Signatures of Human Health Trajectories
Jul 19, 2023 8:00 am EDT FOXO Technologies Launches Bioinformatics Services to Revolutionize Epigenetic Data Analysis
Jun 16, 2023 5:30 am EDT FOXO Technologies Inc. Announces Receipt of Notice of Non-Compliance with NYSE Continued Listing Requirements